BMRA · Biomerica Inc
$1.62
At close · Jul 27
Going-concern doubt
— flagged Apr 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Apr 13, 2026
Market Cap
$4.90M
Shares
3.09M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gary Lu | CFO | $311,769 |
| Zackary Irani | CEO | $201,034 |
| Allen Barbieri | Chairman | $127,928 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gary Lu | CFO | $385,636 |
| Zackary Irani | CEO | $360,103 |
| Allen Barbieri | Chairman | $243,983 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gary Lu | CFO | $205,098 |
| Steve Sloan | CFO | $190,733 |
| Zackary Irani | CEO | $141,250 |
| Allen Barbieri | Chairman | $126,250 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Zackary Irani | CEO | $491,333 |
| Allen Barbieri | Chairman | $355,954 |
| Steve Sloan | CFO | $347,533 |
| Gary Lu | CFO | — |